Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/28/2025 | $3.00 | Buy | H.C. Wainwright |
| 12/16/2024 | Neutral → Underweight | Analyst | |
| 12/13/2024 | Buy → Neutral | Chardan Capital Markets | |
| 12/13/2024 | Buy → Hold | Truist | |
| 12/13/2024 | $11.00 → $3.00 | Buy → Hold | Stifel |
| 12/11/2024 | $7.00 → $4.00 | Overweight → Equal Weight | Wells Fargo |
| 11/25/2024 | $13.00 → $1.00 | Buy → Underperform | BofA Securities |
| 11/6/2024 | In-line → Outperform | Evercore ISI |
4 - Editas Medicine, Inc. (0001650664) (Issuer)
4 - Editas Medicine, Inc. (0001650664) (Issuer)
4 - Editas Medicine, Inc. (0001650664) (Issuer)